Redox Bioscience Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

Redox Bioscience General Information

Description

Developer of thioredoxin based drugs designed to treat respiratory diseases. The company's drugs are used to cure stress associated disorders, enabling healthcare providers to treat the patients and improve their lives.

Contact Information

Website
www.rbs-i.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 6-2 Higashimarutacho Sakyo-ku
  • Kyoto-fu
  • Kyoto, 606-8395
  • Japan
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 6-2 Higashimarutacho Sakyo-ku
  • Kyoto-fu
  • Kyoto, 606-8395
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Redox Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jul-2021 Completed Generating Revenue
1. Later Stage VC 01-Mar-2017 Completed Startup
To view Redox Bioscience’s complete valuation and funding history, request access »

Redox Bioscience Patents

  • 74

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

Redox Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2015177782-A Method of producing liquor or fermented seasoning Pending 18-Jun-2014
JP-2012025776-A Function restoration agent for retina neurocyte Active 18-Oct-2011
JP-5010045-B2 Functional recovery agent for photodamaged retinal neurons Inactive 18-Oct-2011
JP-WO2011102460-A1 Preventive or therapeutic agent for gastric ulcer, orally administered drug, and method for producing preventive or therapeutic agent for gastric ulcer Pending 19-Feb-2010
WO-2011102460-A1 Prophylactic or therapeutic agent for gastric ulcer, medicinal agent for oral administration, and process for production of prophylactic or therapeutic agent for gastric ulcer Inactive 19-Feb-2010 A61K36/06
To view Redox Bioscience’s complete patent history, request access »

Redox Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Redox Bioscience FAQs

  • When was Redox Bioscience founded?

    Redox Bioscience was founded in 2001.

  • Where is Redox Bioscience headquartered?

    Redox Bioscience is headquartered in Kyoto, Japan.

  • What is the size of Redox Bioscience?

    Redox Bioscience has 6 total employees.

  • What industry is Redox Bioscience in?

    Redox Bioscience’s primary industry is Drug Discovery.

  • Is Redox Bioscience a private or public company?

    Redox Bioscience is a Private company.

  • What is Redox Bioscience’s current revenue?

    The current revenue for Redox Bioscience is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process